Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 23 Jun 2026 for Agios Pharmaceuticals, INC..
Filing timeline
BuySaleKaye I. Foster-Cheek
Insider track record
Disclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kaye I. Foster-Cheek: trading record in brief
Kaye I. Foster-Cheek (board member) discloses dealings in Agios Pharmaceuticals, Inc. to SEC (Form 4). In total, 22 filings cover trades dated from 26 February 2018 to 18 June 2026.
The open-market record consists of 8 sales worth €1.9M, with no purchase. The rest of the record consists of 12 option exercises.
The newest entry dates from 23 June 2026: an option exercise, in Agios Pharmaceuticals, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kaye I. Foster-Cheek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
2,816 sharesCommon stockSEC:0001439222-26-000103:0
2,120 shares0Common stockSEC:0001439222-25-000057:0
3,388 shares0Common stockSEC:0001439222-24-000091:0
1,285 shares@ US$31.628.1% of flowCommon stockSEC:0001439222-24-000061:0
300 shares@ US$32.211.9% of flowCommon stockSEC:0001439222-24-000058:0
25,000 shares@ US$18.0989.9% of flowCommon stockSEC:0001439222-23-000125:0
4,975 shares0Common stockSEC:0001439222-23-000097:0
2,200 shares0Common stockSEC:0001439222-23-000006:0
1,585 shares0Common stockSEC:0001439222-22-000048:0
1,686 shares0Common stockSEC:0001439222-21-000053:0
10 of 10 declarations
